The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Judge pauses Trump funding freeze order until Feb. 3
A group of nonprofits sued the Trump administration seeking to block a funding freeze on federal grants and loans worth potentially trillions of dollars.
Sony raises guidance on gaming strength, quarterly operating profit beats estimates
Sony raised sales guidance for the full year and posted operating profit that smashed analyst expectations after a strong quarter for its gaming business.
Trump tariffs could lead to a summer drop-off in economic activity after an ‘artificially high’ start, Chicago Fed chief says
Chicago Fed president Austan Goolsbee forecasts a potential short-term economic bump from President Trump’s tariffs, followed by a summer drop-off.